TY  - JOUR 
AU  - Chaladaj, Wojciech
AU  - Arufe Gonda, Mª del Carmen
AU  - Lucio-Martínez, Fátima
AU  - Fafián Labora, Juan A
PY  - 2025
UR  - http://hdl.handle.net/20.500.11940/20202
AB  - [EN] Estrogen-responsive breast cancer has been treated with tamoxifen since 1998, yet challenges such as limited selectivity and emerging resistance remain significant hurdles to improving therapeutic outcomes. In recent years, the incorporation of...
LA  - eng
TI  - Study of tamoxifen derived perfluoroalkylated olefins in breast cancer treatment
DO  - 10.1016/j.bioorg.2025.108525
T2  - Bioorganic chemistry
M2  - 108525
KW  - CHUAC
KW  - INIBIC
VL  - 161
ER  -